Health Equity in Biomarker Testing and Targeted Therapy
Cancer biomarker testing can lead to targeted therapy which can improve survival and quality of life by connecting patients to the most beneficial treatment for their disease.
Colorectal Cancer Screening and Health Equity
January 15, 2021
In the United States, colorectal cancer (CRC) is the third leading cause of cancer-related deaths in men and in women, and the second most common cause of cancer deaths when men and women are combined. Despite advancements in screening and treatment, CRC does not affect every community the same. New CRC cases (incidence) and deaths (mortality) vary substantially by race, ethnicity, socioeconomic status, and geography.